NeuroMetrix To Present Quell Wearable Pain Technology at National Association of Chain Drug Stores Total Store Expo

WALTHAM, Mass.--()--NeuroMetrix, Inc. (NASDAQ:NURO) today announced that the company, in partnership with Advantage Healthcare, will explore Quell® retail expansion plans with executives from key national and regional drug chains and mass merchandisers at the NCADS Total Store Expo taking place in Boston from August 6 to 9.

"NACDS Total Store Expo is the drug store industry's largest annual meeting," says Clark Brown, Chief Operating Officer of Advantage Healthcare. "We are looking forward to working with NeuroMetrix to further expand Quell distribution and make it available to consumers through retailers across the US."

About Quell Wearable Pain Relief Technology

Quell is FDA cleared and designed for the millions of people suffering from chronic pain. The advanced wearable technology delivers 100% drug free relief and is available without a prescription. Quell can be used during the day while active, and at night while sleeping. Quell gives users the option to start, stop, and adjust therapy discreetly via their smartphone. It also provides therapy utilization and advanced sleep tracking. Quell is available at select healthcare professionals and retailers. To find a Quell retailer, visit the Store Locator at QuellRelief.com.

About Advantage Consumer Healthcare

Advantage Consumer Healthcare is a full-service, sales, marketing and supply chain company that manages over 45 Brands representing over $2 Billion in retail sales. The ACH team average 25 years of experience and have worked in senior roles with some of the best healthcare companies in the world, and has a successful track record helping to create new categories in the OTC healthcare space including Lip Care, Smoking Control & Weight Control.

About NeuroMetrix

NeuroMetrix is an innovative healthcare company that develops wearable medical technology and point-of-care tests that help patients and physicians better manage chronic pain, nerve diseases, and sleep disorders. The company is located in Waltham, Massachusetts and was founded as a spinoff from the Harvard-MIT Division of Health Sciences and Technology in 1996. For more information, please visit www.NeuroMetrix.com.

Contacts

NeuroMetrix, Inc.
Thomas T. Higgins, 781-314-2761
SVP and Chief Financial Officer
neurometrix.ir@neurometrix.com

Contacts

NeuroMetrix, Inc.
Thomas T. Higgins, 781-314-2761
SVP and Chief Financial Officer
neurometrix.ir@neurometrix.com